Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis
Medical Sciences · 2025
DOI: 10.3390/medsci13030188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, 2025. Verfasst von Juan A Encarnación und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Virgen de la Arrixaca University Clinical Hospital, 30120 Murcia, Spain. Hauptthemen laut MEDLINE: Kidney Transplantation, Acute Kidney Injury, Tissue Donors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The shortage of donor kidneys has prompted interest in using organs from donors with severe acute kidney injury (AKI), but robust data on outcomes from donors with AKIN stage 3 remain limited.
Methods
This single-centre, retrospective cohort study compared outcomes of kidney transplants from deceased donors with AKIN stage 3 AKI to matched non-AKI donors (n = 57 per group; matched by donor age ±5 years, year of transplant, and major cardiovascular risk factors). Primary outcomes were delayed graft function (DGF), death-censored graft survival, and patient survival. Secondary outcomes included renal function at follow-up.
Results
DGF occurred in 54.4% (31/57) of AKIN 3 recipients vs. 33.3% (19/57) of non-AKI recipients (risk difference 21.1%, 95% CI 3.1–39.2; p = 0.037). Five-year death-censored graft survival was 94.7% vs. 96.4% (HR 1.28, 95% CI 0.25–6.52; p = 0.645). Five-year patient survival was 84.8% vs. 84.0% (HR 0.96, 95% CI 0.30–3.05; p = 0.979). Median follow-up was 32 months.
Conclusions
In this preliminary, selected kidneys from AKIN stage 3 donors yielded similar medium-term graft and patient survival to non-AKI donors, despite higher DGF incidence. Findings should be interpreted cautiously and confirmed in adequately powered, multicentre studies with extended follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Virgen de la Arrixaca University Clinical Hospital, 30120 Murcia, Spain.
- Murcian Institute of Biosanitary Research, 30120 Murcia, Spain.
- Transplant Coordination, Virgen de la Arrixaca University Clinical Hospital, 30120 Murcia, Spain.
- National Transplant Organization (ONT), 28049 Madrid, Spain.
- Department of Intensive Care Medicine, Virgen de la Arrixaca University Clinical Hospital, 30120 Murcia, Spain.
- Department of Nephrology, Virgen de la Arrixaca University Clinical Hospital, 30120 Murcia, Spain.
ORCID-Profile: Juan A Encarnación, Santiago Llorente, Pablo Luis Guzman Martínez-Valls, Jose L Alonso-Romero, Mario Royo-Villanova
Zitieren
APA
Encarnación, J. A., Coll, E., Manso, C., Llorente, S., Morales, F., Saura, I., López-Cubillana, P., Martínez-Valls, P. L. G., Martínez, G., De la Fuente, I., Cárdenas, E., Alonso-Romero, J. L., Ruiz, P., Moya, J., Domínguez-Gil, B., & Royo-Villanova, M. (2025). Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis. Medical Sciences. https://doi.org/10.3390/medsci13030188
Vancouver
Encarnación JA, Coll E, Manso C, Llorente S, Morales F, Saura I, et al. Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis. Medical Sciences. 2025. doi:10.3390/medsci13030188
BibTeX
@article{Encarnacin2025,
author = {Encarnación, Juan A and Coll, Elisabeth and Manso, Clara and Llorente, Santiago and Morales, Francisco and Saura, Isabel and López-Cubillana, Pedro and Martínez-Valls, Pablo Luis Guzman and Martínez, Gloria and De la Fuente, Isabel and Cárdenas, Enrique and Alonso-Romero, Jose L and Ruiz, Paula and Moya, José and Domínguez-Gil, Beatriz and Royo-Villanova, Mario},
title = {Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13030188}
}
EUVIMED